# Aragen Life Sciences

> Aragen is a fully integrated, technology\-led CRDMO supporting discovery, development and manufacturing for small molecules and biologics\.

Generated by Yoast SEO v28.6, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Biomedical Waste Returns](https://www.aragen.com/ehs/)
- [CPHI Frankfurt 2025](https://www.aragen.com/cphi-frankfurt-2025/)
- [Thank You \- Protein Degraders](https://www.aragen.com/thank-you-protein-degraders/)
- [Corporate Governance](https://www.aragen.com/corporate-governance/)
- [CPHI Japan 2026](https://www.aragen.com/cphi-japan-2026/)

## Posts
- [Enabling Faster Decisions: The Role of Predictable Turnaround Times in DMPK Programs](https://www.aragen.com/enabling-faster-decisions-the-role-of-guaranteed-tat-in-dmpk-programs/)
- [Bridging Material Science and Particle Science: A Roadmap from Molecular Pharmaceutics to Manufacturing Scale](https://www.aragen.com/bridging-material-science-and-particle-science-a-roadmap-from-molecular-pharmaceutics-to-manufacturing-scale/)
- [Faster from Gene to Protein: Building Confidence into Every Development Decision](https://www.aragen.com/faster-from-gene-to-protein-building-confidence-into-every-development-decision/)
- [Choosing the Right CRO for \<i\>In Vivo\</i\> Research](https://www.aragen.com/choosing-the-right-cro-for-in-vivo-research/)
- [Allometric Scaling for Peptides: Myths, Pitfalls, and Predictive Strategies](https://www.aragen.com/allometric-scaling-for-peptides-myths-pitfalls-and-predictive-strategies/)

## Solutions
- [OneHP Platform](https://www.aragen.com/solutions/small-molecules/development/onehp-platform/)
- [Recombinant Protein Production](https://www.aragen.com/solutions/small-molecules/discovery/biology/cell-and-protein-sciences/recombinant-protein-production/): Recombinant protein production using multiple expression platforms to deliver high\-quality, proteins for your research needs\.
- [Protein Characterization](https://www.aragen.com/solutions/small-molecules/discovery/biology/cell-and-protein-sciences/protein-characterization/): Extensive characterization of the purified proteins to deliver high\-quality proteins\.
- [Technology Transfer](https://www.aragen.com/solutions/small-molecules/development/drug-substance/technology-transfer/): Ensures seamless drug substance technology transfer across all phases, mitigating technical, regulatory, and quality risks for successful commercial\-scale production\.
- [Process Safety and Risk Management](https://www.aragen.com/solutions/small-molecules/development/drug-substance/process-safety-and-risk-management/): Aragen ensures process safety and risk management across all phases, using advanced screening, risk assessments, and regulatory compliance for secure development\.

## News
- [India’s race for the CDMO crown](https://www.aragen.com/news/indias-race-for-the-cdmo-crown/)
- [Aragen Life Sciences to begin Operations at OneHP, an Integrated High\-potency Platform in Hyderabad](https://www.aragen.com/news/aragen-life-sciences-to-begin-operations-at-onehp-an-integrated-high-potency-platform-in-hyderabad/)
- [Aragen’s biologics manufacturing facility completes qualification; first  GMP batches in late July 2025](https://www.aragen.com/news/aragens-biologics-manufacturing-facility-completes-qualification-first-gmp-batches-in-late-july-2025/)
- [Aragen appoints Aniel Khubchandani as CEO of Development and Manufacturing Solutions business](https://www.aragen.com/news/aragen-appoints-aniel-khubchandani-as-ceo-of-development-and-manufacturing-solutions-business/)
- [Aragen strengthens Discovery leadership with the appointment of Neeraj Garg as CEO, Discovery Solutions Division](https://www.aragen.com/news/aragen-strengthens-discovery-leadership-with-the-appointment-of-neeraj-garg-as-ceo/)

## Events
- [BIO International Convention](https://www.aragen.com/events/bio-international-convention/)
- [IPF Summit](https://www.aragen.com/events/ipf-summit-3/)
- [Discovery on Target](https://www.aragen.com/events/discovery-on-target-3/)
- [Antibody Engineering \& Therapeutics](https://www.aragen.com/events/antibody-engineering-therapeutics-2/)
- [BioProcess International Europe](https://www.aragen.com/events/bioprocess-international-europe/)

## Awards
- [Aragen’s Integrated Single\-Use, Multi\-Product Biologics CDMO Campus in Bengaluru received this recognition in the Engineering Design category\.](https://www.aragen.com/awards/aragens-integrated-single-use-multi-product-biologics-cdmo-campus-in-bengaluru-received-this-recognition-in-the-engineering-design-category/)
- [Awarded “5 Star Rating” for commitment to excellence on EHS practices at the CII\-SR EHS Excellence Awards for the year 2018](https://www.aragen.com/awards/gvk-bio-awarded-5-star-rating-for-excellence-in-ehs-practices-at-the-cii-southern-region-ehs-excellence-awards/)
- [Our facility at Visakhapatnam, Andhra Pradesh was awarded the “3 Star Rating” for commitment to excellence on EHS practices at the CII\-SR EHS Excellence Awards for the year 2019](https://www.aragen.com/awards/gvk-bio-wins-the-3-star-rating-award-southern-region-for-demonstrating-best-in-class-environmental-health-and-safety-practices/)
- [Received Great Place to Work certification for the period of January 2020 till December 2020](https://www.aragen.com/awards/aragen-is-the-first-biopharmaceutical-services-company-out-of-india-to-be-great-place-to-work-certifiedtm-certified/)
- [Awarded the “Best Supply Chain Strategy and Design of the Year” at the Logistics and Supply Chain Tech Innovation Awards 2020](https://www.aragen.com/awards/gvk-bio-wins-best-supply-chain-strategy-design-of-the-year-biopharma-at-the-10th-inflection-conference-awards/)

## Leaders
- [Manmahesh Kantipudi](https://www.aragen.com/leadership/manni-kantipudi/)
- [Robert Richard Ruffolo](https://www.aragen.com/leadership/dr-robert-r-ruffolo/)
- [Sachin Anand Dharap](https://www.aragen.com/leadership/sachin-dharap/)
- [Ramakrishna Kasturi](https://www.aragen.com/leadership/ramakrishna-kasturi/)
- [Aaron Leigh Schacht](https://www.aragen.com/leadership/aaron-leigh-schacht/)

## Publications
- [Effect of sex and food on the pharmacokinetics of different classes of BCS drugs in rats after cassette administration](https://www.aragen.com/publications/effect-of-sex-and-food-on-the-pharmacokinetics-of-different-classes-of-bcs-drugs-in-rats-after-cassette-administration/): Satish Kumar \<sup\>a\</sup\>, Surendra Yadav Ravulapalli \<sup\>b\</sup\>, Sudhir Kumar Tiwari \<sup\>b\</sup\>, Sumeet Gupta \<sup\>a\</sup\>,\*, Anroop B\. Nair \<sup\>c\</sup\>,\<br\>Shery Jacob \<sup\>d\</sup\>
- [Effect of modulation of alimentary and formulation pH on the pharmacokinetics of BCS\-Class I, II, III, and IV compounds in rats following cassette dosing](https://www.aragen.com/publications/effect-of-modulation-of-alimentary-and-formulation-ph-on-the-pharmacokinetics-of-bcs-class-i-ii-iii-and-iv-compounds-in-rats-following-cassette-dosing/): Satish Kumar , Lakshmi Prasanna Tattala , Ravi Akkireddy , Satinder Singh , Sudhir Kumar Tiwari , Pratima Srivastava
Sumeet Gupta \& Anroop Nair
- [The Influence of Drug\-Like Concepts on Decision\-Making in Medicinal Chemistry](https://www.aragen.com/publications/the-influence-of-drug-like-concepts-on-decision-making-in-medicinal-chemistry/): Paul D\. Leeson, Brian Springthorpe
Nature Reviews Drug Discovery, 2007
- [Synthesis and Antibacterial Activity of 6\-Substituted Anacardic Acid Derivatives](https://www.aragen.com/publications/synthesis-and-antibacterial-activity-of-6-substituted-anacardic-acid-derivatives/): Subhakara Reddy Nallamilli, Ravi Kumar V, Himabindu V, B Ram, Srinivas Rao Aalapati
Letters in Drug Design \& Discovery, 2011, 8, 972\-979
- [Palladium Catalyzed Synthesis of Quinazolino \[1,4\] Benzodiazepine Alkaloids and Analogues](https://www.aragen.com/publications/palladium-catalyzed-synthesis-of-quinazolino-14-benzodiazepine-alkaloids-and-analogues/): Kumaraswamy Sorra, Srinivas Pusuluri, K Mukkanti
Tetrahedron 2012; 68, 2001\-2006

## Resources
- [Aragen OneHP](https://www.aragen.com/resource/aragen-onehp/)
- [From Exposure to Evidence: The Critical Role of Analytical Chemistry in Modern Safety Assessment](https://www.aragen.com/resource/from-exposure-to-evidence-the-critical-role-of-analytical-chemistry-in-modern-safety-assessment/)
- [Accelerating Timelines Through Integrated Drug Substance \(DS\) and Drug Product \(DP\) Development](https://www.aragen.com/resource/accelerating-timelines-through-integrated-drug-substance-ds-and-drug-product-dp-development/)
- [Unlocking the Potential of Cyclic and Conjugated Peptides Through Integrated Discovery and Development](https://www.aragen.com/resource/unlocking-the-potential-of-cyclic-and-conjugated-peptides-through-integrated-discovery-and-development/)
- [Accelerating FDA Fast\-Track Monoclonal Antibodies through integrated strategy](https://www.aragen.com/resource/accelerating-fda-fast-track-monoclonal-antibodies-through-integrated-strategy/)

## Training Calendar
- [April 2025](https://www.aragen.com/training_calendar/april-2025/)
- [March 2025](https://www.aragen.com/training_calendar/march-2025/)
- [February 2025](https://www.aragen.com/training_calendar/february-2025/)
- [January 2025](https://www.aragen.com/training_calendar/january-2025/)
- [December 2024](https://www.aragen.com/training_calendar/december-2024/)

## Brochures
- [Safety Assessments for Specialty Chemicals](https://www.aragen.com/brochure/bio-safety-assessment/)
- [Navigating Recombinant Protein Production– Leveraging Aragen’s Multifaceted Expression Systems](https://www.aragen.com/brochure/navigating-recombinant-protein-production-leveraging-aragens-multifaceted-expression-systems/)
- [Modalities for Mechanistic Exploration in Agrochemical Solutions](https://www.aragen.com/brochure/modalities-for-mechanistic-exploration-in-agrochemical-solutions/)
- [Process Safety, Dust Explosion Testing Capabilities](https://www.aragen.com/brochure/process-safety-dust-explosion-testing-capabilities/)
- [Flow Chemistry Solutions](https://www.aragen.com/brochure/flow-chemistry-solutions/)

## Articles
- [Reducing Cost of Goods While Maintaining GMP Quality: Advanced Media and Process Design for Biologics](https://www.aragen.com/article/reducing-cost-of-goods-while-maintaining-gmp-quality-advanced-media-and-process-design-for-biologics/)
- [Building Regulatory Confidence Through Analytical Excellence](https://www.aragen.com/article/building-regulatory-confidence-through-analytical-excellence/)
- [In Vitro Phosphate Binding Studies \& Analytical Strategies for Characterization and Sameness Assessment](https://www.aragen.com/article/in-vitro-phosphate-binding-studies-analytical-strategies-for-characterization-and-sameness-assessment/)
- [Continuous Flow Chemistry vs\. Batch: When and Why to Switch at Scale](https://www.aragen.com/article/continuous-flow-chemistry-vs-batch-when-and-why-to-switch-at-scale/)
- [Cell Line Development: Reducing Timeline to IND Submission](https://www.aragen.com/article/cell-line-development-reducing-timeline-to-ind-submission/)

## Case Studies
- [Optimizing Co\-Crystal Crystallization for Robustness and Scalability](https://www.aragen.com/casestudy/optimizing-co-crystal-crystallization-for-robustness-and-scalability/)
- [Integrating Drug Substance and Drug Product Development to Accelerate Clinical Timelines](https://www.aragen.com/casestudy/integrating-drug-substance-and-drug-product-development-to-accelerate-clinical-timelines/)
- [The incidence of lung and spleen tumors in positive control group of Tg\.rasH2 mice sourced from CLEA, Japan](https://www.aragen.com/casestudy/the-incidence-of-lung-and-spleen-tumors-in-positive-control-group-of-tg-rash2-mice-sourced-from-clea-japan/)
- [Comprehensive Preclinical Development Program for a COVID mRNA Vaccine](https://www.aragen.com/casestudy/comprehensive-preclinical-development-program-for-a-covid-mrna-vaccine/)
- [A Streamlined Crystallization Strategy to Deliver High\-Purity R\-Isomer](https://www.aragen.com/casestudy/a-streamlined-crystallization-strategy-to-deliver-high-purity-r-isomer/)

## Videos
- [Process Safety Lab](https://www.aragen.com/video/process-safety-lab/)
- [Tox Services \- Capabilities and Infrastructure](https://www.aragen.com/video/tox-services-capabilities-and-infrastructure/)
- [Discovery Chemistry Facilities](https://www.aragen.com/video/discovery-chemistry-facilities/)
- [Manufacturing Facility at Visakhapatnam, India](https://www.aragen.com/video/manufacturing-facility-at-visakhapatnam-india/)
- [Discovery Biology R\&D Facilities](https://www.aragen.com/video/discovery-biology-rd-facilities/)

## Whitepapers
- [Enabling Next\-Generation Therapeutics through Scalable Chemical Development](https://www.aragen.com/whitepaper/enabling-next-generation-therapeutics-through-scalable-chemical-development/)
- [De\-Risking Biologics Technology Transfer: A Process\-First Approach to Seamless Site Transitions](https://www.aragen.com/whitepaper/de-risking-biologics-technology-transfer-a-process-first-approach-to-seamless-site-transitions/)
- [GMP Manufacturing Integration: Supporting Seamless Scale\-up from Lab to Commercial Production](https://www.aragen.com/whitepaper/gmp-manufacturing-integration-supporting-seamless-scale-up-from-lab-to-commercial-production/)
- [From Molecule to Man: How Translational Formulation Strategy De\-Risks the Path from DMPK/Tox to First\-in\-Human](https://www.aragen.com/whitepaper/from-molecule-to-man-how-translational-formulation-strategy-de-risks-the-path-from-dmpk-tox-to-first-in-human/)
- [Analytical Strategies for Long\-Acting Drug Formulation Development: Solubility Optimization, Release Characterization, and Sustained Performance](https://www.aragen.com/whitepaper/analytical-strategies-for-long-acting-drug-formulation-development-solubility-optimization-release-characterization-and-sustained-performance/)

## Webinars
- [Beyond DC50: Designing Protein Degraders for Potency, Selectivity, and Clinical Translation](https://www.aragen.com/webinar/beyond-dc50-designing-protein-degraders-for-potency-selectivity-and-clinical-translation/)
- [On\-Demand Webinar \- From Exposure to Evidence: The Critical Role of Analytical Chemistry in Modern Safety Assessment](https://www.aragen.com/webinar/on-demand-webinar-from-exposure-to-evidence-the-critical-role-of-analytical-chemistry-in-modern-safety-assessment/)
- [On\-Demand Webinar \- Unlocking the Potential of Cyclic and Conjugated Peptides Through Integrated Discovery and Development](https://www.aragen.com/webinar/on-demand-webinar-unlocking-the-potential-of-cyclic-and-conjugated-peptides-through-integrated-discovery-and-development/)
- [From Exposure to Evidence: The Critical Role of Analytical Chemistry in Modern Safety Assessment](https://www.aragen.com/webinar/from-exposure-to-evidence-the-critical-role-of-analytical-chemistry-in-modern-safety-assessment/)
- [Unlocking the Potential of Cyclic and Conjugated Peptides Through Integrated Discovery and Development](https://www.aragen.com/webinar/unlocking-the-potential-of-cyclic-and-conjugated-peptides-through-integrated-discovery-and-development/)

## Categories
- [Uncategorized](https://www.aragen.com/category/uncategorized/)

## Leader Categories
- [Board of Directors](https://www.aragen.com/leadership_category/board-of-directors/)
- [Senior Management Personnel](https://www.aragen.com/leadership_category/management-team/)
- [Development and Manufacturing Solutions](https://www.aragen.com/leadership_category/development-and-manufacturing-solutions/)
- [Business Development](https://www.aragen.com/leadership_category/business-development/)
- [Discovery Solutions](https://www.aragen.com/leadership_category/discovery-solutions/)

## News Categories
- [Media](https://www.aragen.com/news_category/media/)
- [Press Release](https://www.aragen.com/news_category/press-release/)
- [Webinar](https://www.aragen.com/news_category/webinar/)

## Publication Categories
- [Chemistry](https://www.aragen.com/pubication_category/chemistry/)
- [Biology](https://www.aragen.com/pubication_category/biology/)

## Resource Types
- [Brochures](https://www.aragen.com/resource_type/brochures/)
- [Articles](https://www.aragen.com/resource_type/articles/)
- [Whitepapers](https://www.aragen.com/resource_type/whitepapers/)
- [Case Studies](https://www.aragen.com/resource_type/case-studies/)
- [On\-demand Webinars](https://www.aragen.com/resource_type/on-demand-webinars/)

## Resource Science
- [Biology](https://www.aragen.com/resource_science/biology/)
- [Development](https://www.aragen.com/resource_science/development/)
- [Biologics](https://www.aragen.com/resource_science/biologics/)
- [Chemistry](https://www.aragen.com/resource_science/chemistry/)
- [SAS/Toxicology](https://www.aragen.com/resource_science/sas-toxicology/)

## Optional
- [Sitemap index](https://www.aragen.com/sitemap_index.xml)